<DOC>
	<DOCNO>NCT00982189</DOCNO>
	<brief_summary>This study fund American Heart Association . The goal research prevent early cardiovascular damage symptom develop person HIV infection . Evidence suggest take low dos blood pressure cholesterol medication reduces risk heart disease person increase risk ( case HIV infection ) . Participants take HIV treatment 'undetectable ' viral load , NOT need treatment high blood pressure cholesterol may eligible enroll . Participants take low dose cholesterol medication ( placebo ) low dose blood pressure medication ( placebo ) , see 3 study visit 4 month .</brief_summary>
	<brief_title>Cardiovascular Prevention Persons With HIV</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Pravastatin</mesh_term>
	<mesh_term>Lisinopril</mesh_term>
	<criteria>HIV Infection viral load 'undetectable ' take antiretroviral therapy Age ≥40 Framingham risk score ( FRS ) ≥5 % , ≥3 % ≥5 year exposure antiretroviral therapy Known cardiovascular disease Framingham risk score ( FRS ) ≥20 % Blood pressure ≥140/90 LDL cholesterol ≥160 ( FRS &lt; 10 % ) , ≥130 ( FRS 1020 % ) Currently take , medication contraindication take , 'statin ' , ACE inhibitor , angiotensin receptor blocker medication Cirrhosis plasma ALT/AST level &gt; 2x upper limit normal Chronic kidney disease creatinine &gt; 2.0mg/dL Triglycerides &gt; 500mg/dL</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>treatment experience</keyword>
</DOC>